Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results

Strong Sales Growth and Strategic Advances Position EW for Future Expansion

Related Keywords

Japan ,Bernard Zovighian ,Edwards Lifescience ,Edwards Lifesciences ,Edwards Lifesciences Corp ,Transcatheter Aortic Valve Replacement ,Sales Growth ,Diluted Eps ,Tavr ,Share Repurchase ,